Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Different Office SBP and DBP Categories Mancia G et al Hypertension. 2005;45:1072.

Slides:



Advertisements
Similar presentations
1 Hypertension 2002: An Overview. 2 Leading Risks For Death (World Health Organization 1995)
Advertisements

Age (years) Gender (Males), n (%) Dialysis duration (years) Hemoglobin (mg / dl) Pre dialysis SBP (mmHg) Pre dialysis DBP(mmHg) Post dialysis SBP (mmHg)
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Maximum home blood pressure: a novel indicator of target-organ damage in hypertension  Blood pressure variability has recently been shown to be a strong.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.
A Controlled Trial of Renal Denervation for Resistant Hypertension
CHAPTER 8: Blood Pressure Control and Dyslipidaemia in Patients on Dialysis S. Prasad Menon Hooi Lai Seong Lee Wan Tin Sunita Bavanandan Source: 21 st.
Study Flow Diagram Holvoet P, et al. JAMA 2008;299: The Figure shows the selection of 1889 participants who did not have metabolic syndrome at year.
Taipei Medical University The correlation between Geriatric Nutritional Risk Index and nutritional status in hemodialysis patients I ntroduction O bjective.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Exercise and Weight Loss Reduce Blood Pressure in.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Category Sex Systolic BP (mmHg) Men (n=58) Women (n=106) P value
Dr John Cox Diabetes in Primary Care Conference Cork
From ESH 2016 | POS 4C: A. Power, MD
Figure 1. Schedule of the study
Eoin O’Brien, DSc, MD, Eamon Dolan, MD, FRCPI  Clinical Therapeutics 
Itamar Grotto, Michael Huerta, Ehud Grossman and Yehonatan Sharabi
Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;
Flowchart of participants
Blood Pressure Variability at Normal and High Blood Pressure
Modeling Hemodynamic Profiles by Telemetry in the Rat
From ESH 2016 | POS 3C: Luiz Aparecido Bortolotto, MD, PhD
White-coat Hypertension
BACKGROUND RESULTS OBJECTIVES METHODS CONCLUSIONS REFERENCES
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Attenuation of the “White-Coat Effect” by Antihypertensive Treatment and Regression of Target Organ Damage by Gianfranco Parati, Luisa Ulian, Lorena Sampieri,
Circ Cardiovasc Qual Outcomes
by Katie Ayers, Loretta M. Byrne, Anthony DeMatteo, and Nancy J. Brown
Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic
Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before.
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Simple Cysts in Donor Kidney Contribute to Reduced Allograft Function
Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.
Naoki Watanabe et al. BTS 2017;2:
Franklin SS, et al. Circulation 2009;119:243-50
Description of studies for pooled analyses
End point Net change with soy supplements vs control (95% CI) p
© The Author(s) Published by Science and Education Publishing.
Chapter 28 Nutrition, Lifestyle, and Hypertension
Fig. 3 Fbln4E57K/E57K mice develop large artery stiffness and systolic hypertension. Fbln4E57K/E57K mice develop large artery stiffness and systolic hypertension.
Ao, aorta; CEOA, corrected effective orifice area; CFD, color-flow Doppler; CW, continuous-wave; DBP, diastolic blood pressure; LV EDP, left ventricular.
Influence of possible intermediary variables on PR interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.
Baseline Characteristics of 400 Women Who Subsequently Developed Incident Hypertension (Case Subjects) and 400 Women Who Remained Free of Hypertension.
Clinical Characteristics and Atheroma Burden of Subjects at Baseline Stratified According to Gender Nicholls SJ. et al. J Am Coll Cardiol 2007;49:
William T. Abraham et al. JCHF 2015;3:
A.V. Khera et al. N Engl J Med 2011;364:127-35
Baseline Characteristics, Blood Pressures, and Laboratory Values
Masanobu Ishii et al. BTS 2017;2:
Rahilly-Tierney CR et al. Circulation 2009;120:1491-7
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
Baseline Lipid Parameters and Characteristics Among 3110 Men According to Quintiles of Total Cholesterol Ruben O. Halperin et al, Hypertension 2006;47;45-50.
Flow chart of the 1683 study members at age 60–64 years by hypertension (HT) status. Flow chart of the 1683 study members at age 60–64 years by hypertension.
The volume per centre plotted against clinical outcomes which included Hospital Anxiety and Depression Scale (HADS) score, exercise 150 min, smoking, body.
RECORD Study: Enrollment and Outcomes
Characteristics of SIRCA Participants
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Influence of possible intermediary variables on QTc interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.
Associations between type of MI and incident HF
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
End point Valsartan Valsartan+HCTZ p
Associations of VO2peak to significant predictors.
Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.
Distribution of SDS for serum creatinine, serum BUN, SBP, and DBP per quintiles of KS. Quintiles are expressed in SDS (see Figure 1B): 1st quintile,
Pulmonary artery pressure in a) healthy subjects and b) pulmonary hypertension (PH) subjects. Pulmonary artery pressure in a) healthy subjects and b) pulmonary.
The distribution of systolic blood pressure (SBP) in male (blue) and female (red) athletes with mean values (SD) presented for each sex (panel A). The.
Relationship between 6-month all-cause mortality and the three types of heart failure adjusted for age ≥75 years, peripheral edema at admission, systolic.
Receiver operating characteristic curve showing results for two selected models, applied to the testing cohort. Receiver operating characteristic curve.
Presentation transcript:

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Different Office SBP and DBP Categories Mancia G et al Hypertension. 2005;45:1072

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Office Systolic Blood Pressure Quartiles Mancia G et al Hypertension. 2005;45:1072

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Home SBP Quartiles Mancia G et al Hypertension. 2005;45:1072

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in 24-Hour SBP Quartiles Mancia G et al Hypertension. 2005;45:1072

Person Correlation Coefficient Between Metabolic, Anthropometric, Blood Pressure, and Heart Rate Values Mancia G et al Hypertension. 2005;45:1072

Multivariate Analysis With Glycemia as the Dependent Variable Mancia G et al Hypertension. 2005;45:1072

Multivariate Analysis With Serum Total Cholesterol as the Dependent Variable Mancia G et al Hypertension. 2005;45:1072